Mivacurium in infants and children

Paediatric Anaesthesia

Volumn 7, Issue 3, 1997, Pages 183-190

  Goudsouzian, Nishan G ^a,b  

^a HARVARD MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

combination with other relaxants; effective doses; mivacurium; neuromuscular relaxants; side effects

Indexed keywords

EDROPHONIUM; MIVACURIUM; NEOSTIGMINE;

CHILD; DRUG ANTAGONISM; DRUG EFFECT; ENDOTRACHEAL INTUBATION; HISTAMINE RELEASE; HUMAN; INFANT; MUSCLE RELAXATION; NEUROMUSCULAR BLOCKING; PEDIATRIC ANESTHESIA; PRIORITY JOURNAL; REVIEW;

EID: 0030910215     PISSN: 11555645     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1460-9592.1997.d01-74.x     Document Type: Review

References (53)

1. Lien CA, Schmith VD, Embree PB et al. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Anesthesiology 1994; 80: 1296-1302.
2. Frampton JE, McTavish D. Mivacurium. A review of its pharmacology and therapeutic potential in general anaesthesia. Drugs 1993; 45: 1066-1089.
3. Cook DR, Stiller RL, Weakly JN et al. In vitro metabolism of mivacurium chloride (BW B1090U) and succinylcholine. Anesth Analg 1989; 68: 452-456.
4. Goudsouzian NG, Alifimoff JK, Eberly C et al. Neuromuscular and cardiovascular effects of mivacurium in children. Anesthesiology 1989; 70: 237-242.
5. Sarner JB, Brandom BW, Woelfel SK et al. Clinical pharmacology of mivacurium chloride (BW B1090U) in children during nitrous oxide-halothane and nitrous oxide-narcotic anesthesia. Anesth Analg 1989; 68: 116-121.
6. Basta AJ. Clinical pharmacology of mivacurium chloride: A review. J Clin Anesth 1992; 4: 153-163.
7. Goudsouzian NG, Denman W, Schwartz A et al. Pharmacodynamic and hemodynamic effects of mivacurium in infants anesthetized with halothane and nitrous oxide. Anesthesiology 1993; 79: 919-925.
8. Woelfel SK, Brandom BW, McCowan F et al. Clinical pharmacology of mivacurium in pediatric patients less than two years during nitrous oxide-halothane. Anesth Analg 77: 713-720.
9. McCluskey A, Meakin G. Dose-response and minimum time to satisfactory intubation condition after mivacurium in children. Anaesthesia 1996; 51: 438-441.
10. Meretoja OA. Neuromuscular blocking agents in paediatric patients: influence of age on the response. Anaesth and Intens Care 1990; 18: 440-448.
11. Gronert BJ, Brandom BW. Neuromuscular blocking drugs in infants and children. Ped Clin North America 1994; 41: 73-91.
12. Shorten G, Crawford M, St. Louis P. The neuromuscular blocking effects of mivacurium chloride in children during propofol anesthesia. Anesth Analg 1996; 82: 1170-1175.
13. Simhi E, Brandom BW, Gronert BJ et al. Timing of intubation in children after 300 μg/kg of mivacurium. Anesthesiology 33: A902, 1995.
14. Mangat PS, Evans DEN, Harmer M et al. A comparison between mivacurium and suxamethonium in children. Anaesthesia 1993; 48: 866-869.
15. Kaplan RF, Garcia M, Hannallah RS. Mivacurium induced neuromuscular blockade during sevoflurane and halothane anaesthesia in children. Can J Anaesth 1995; 42: 16-20.
16. Alifimoff JK, Goudsouzian NG. Continuous infusion of mivacurium in children. Brit J Anaesth 1989; 63: 520-524.
17. Brandom BW, Sarner JB, Woelfel SK et al. Mivacurium infusion requirements in pediatric surgical patients during nitrous oxide-halothane and during nitrous-narcotic anesthesia. Anesth Analg 1990; 71: 16-22.
18. Meretoja OA, Olkkola KT. Pharmacodynamics of mivacurium in children, using a computer-controlled infusion. Brit J Anaesth 1993; 71: 232-237.
19. Meretoja OA, Taivainen T, Wirtavuori K. Pharmacodynamics of mivacurium in infants. Brit J Anaesth 1994; 73: 490-493.
20. Litman RS, Younan MM, Patt RB et al. Postoperative recurrent paralysis in an infant after mivacurium infusion. Can J Anaesth 1994; 41: 75-89.
21. Savarese JJ, Ali HH, Basta SJ et al. The clinical neuromuscular pharmacology of mivacurium chloride (BW B1090U): A short-acting nondepolarizing ester neuromuscular blocking drug. Anesthesiology 1988; 68: 723-732.
22. Shorten G, Crawford MW, St. Louis P. Dose-related changes in plasma histamine concentration following, mivacurium in children. Anesth Analg 1995; 80: S443.
23. Else TA. Asystole associated with mivacurium. Anaesthesia 1994; 49: 926.
24. Whittaker M. Plasma cholinesterase variants and the anaesthetist. Anaesthesia 1980; 35: 174-179.
25. Shorten G, Crawford MW, St. Louis P. Pseudocholinesterase activity and duration of mivacurium-induced neuromuscular blockade in children. Anesth Analg 1995; 80: S444.
26. Markakis DA, Hart PS, Lau M et al. Does age or pseudocholinesterase activity predict mivacurium infusion rate in children? Anesth Analg 1996; 82: 39-43.
27. Hart PS, McCarthy CJ, Brown R et al. The effect of cholinesterase activity on mivacurium infusion rates. Anesth Analg 1995; 80: 760-763.
28. Kalow W, Staron N. On distribution and inheritance of atypical forms of human serum cholinesterase as indicated by dibucaine numbers. Can J Biochem and Phys 1957; 35: 1305-1317.
29. Lockridge O, Bartels CJ, Vaughan TA et al. Complete amino acid sequence of human serum cholinesterase. J Biology Chem 1987; 262: 549-557.
30. Allerdice PW, Gardner HAR, Galutira D et al. The cloned butylcholinesterase (BCHE) gene maps to a single chromosome site 3q26. Genomics 1991; 11: 452-454.
31. Viby-Mogensen J, Hanel KH. A Danish cholinesterase unit. Acta Anaesth Scand 1977; 20: 405-412.
32. Bevan DR. Prolonged mivacurium-induced neuromuscular block. Anesth Analg 1993; 77: 4-6.
33. Viby-Mogensen J. Succinylcholine neuromuscular blockade in subjects homozygous for atypical plasma cholinesterase. Anesthesiology 1981; 55: 429-434.
34. Ostergaard D, Jensen FS, Jensen E et al. Mivacurium-induced neuromuscular blockade in patients with atypical plasma cholinesterase. Acta Anaesthesiol Scand 1993; 37: 314-318.
35. Goudsouzian NG, d'Hollander AA, Viby-Mogensen J. Prolonged neuromuscular block from mivacurium in two patients with cholinesterase deficiency. Anesth Analg 1993; 77: 183-5.
36. Petersen RS, Bailey PL, Kalameghan R et al. Prolonged neuromuscular block after mivacurium. Anesth Analg 1993; 76: 194-6.
37. Fox MH, Hunt PCW. Prolonged neuromuscular block associated with mivacurium. Brit J Anaesth 1995; 74: 237-238.
38. Sockalingam I, Green DW. Mivacurium-induced prolonged neuromuscular block. Brit J Anaesth 1995; 74: 234-236.
39. Zsigmond EK, Down JR. Plasma cholinesterase activity in newborns and infants. Can Anaesth Soc J 1971; 18: 278-285.
40. Vassallo SA, Denman W, Goudsouzian NG. Plasma cholinesterase activity and dibucaine number in infants and children. Paediatr Anaesth 1994; 4: 313-317.
41. Bevan DR, Kahwaji R, Ansermino JM et al. Residual block after mivacurium with or without edrophonium reversal in adults and children. Anesthesiology 1996; 84: 362-367.
42. Bevan JC, Tousignant, C, Stephenson C et al. Dose responses for neostigmine and edrophonium and antagonists of mivacurium in adults and children. Anesthesiology 1996; 84: 354-361.
43. Watcha MF, Safavi FZ, McCulloch DA et al. Effect of antagonism of mivacurium-induced neuromuscular block on postoperative emesis in children. Anesth Analg 1995; 80: 713-717.
44. Abdulatif M, Al-Ghamdi A, Al-Sanabary M et al. Edrophonium antagonism of intense mivacurium-induced neuromuscular block in children. Brit J Anaesth 1996; 76: 239-244.
45. Naguib M, El-Gammal M, Daoud W et al. Human plasma cholinesterase for antagonism of prolonged mivacurium-induced neuromuscular blockade. Anesthesiology 1995; 82: 1288-1292.
46. Naguib M, Daoud W, El-Gammal M et al. Enzymatic antagonism of mivacurium-induced neuromuscular blockade by human plasma cholinesterase. Anesthesiology 1995; 83: 694-701.
47. Brandom BW, Meretoja OA, Taivainen T et al. Accelerated onset and delayed recovery of neuromuscular block induced by mivacurium preceded by pancuronium in children. Anesth Analg 1993; 76: 988-1003.
48. Jalkanen L, Meretoja OA, Taivainen T et al. Synergism between atracurium and mivacurium compared with that between vecuronium and mivacurium. Anesth Analg 1994; 79: 988-1002.
49. Brandom BW, Gronert BJ, Woelfel SK et al. Lack of synergy between mivacurium and doxacurium or pipecuronium. Anesth Analg 1996; 82A: 546.
50. Brandom BW, Meretoja OA, Gronert BJ et al. Synergy between mivacurium and pancuronium. Anesth Analg 1996; 82A: 548.
51. Goudsouzian NG, Denham W, Matta E. Mivacurium after atracurium in children. Anesth Analg 1994; 79: 345-349.
52. Denman W, Goudsouzian N. Mivacurium infusion requirements following vecuronium: different response between adults and children. Can J Anaesth 1995; 42: 597-602.
53. Cauldwell CB, Lau M, Fisher DM. Is intramuscular mivacurium an alternative to intramuscular succinylcholine? Anesthesiology 1994; 80: 320-325.